Frost & Sullivan Recognizes Epax AS Superiority in the Omega-3 Ingredients Market

Frost & Sullivan Recognizes Epax AS Superiority in the Omega-3 Ingredients Market PR Newswire LONDON, Sept. 28, 2012 -- Derived from fish oil with an optimum EPA:DHA ratio, the cost-effective Epax® products range offers condition specific formulas to edge out competition LONDON, Sept. 28, 2012 /PRNewswire/ -- Based on its recent research on the omega-3 market, Frost & Sullivan presents Epax AS with the 2012 European Frost & Sullivan Award for Product Differentiation Excellence. The company's range of omega-3 industry ingredient products has carved a niche in a crowded market by developing innovative solutions that address specific disorders, unlike competing products that support the general wellbeing of individuals. Omega-3 has earned the name of a beneficial ingredient with proven benefits to address conditions pertaining to heart health, pre and post natal health, cognitive health, eye health, and joint health. The market has many participants, all aiming to provide multiple benefits to end users. "Product differentiation is one of the prime factors that define success in the omega-3 market," said Frost & Sullivan Research Analyst Ashwin Raj Ravinder. "Epax is one of the earliest patrons that have brought in the concept of condition-specific formulas enrooted to target solitary needs of the consumer.